Lipocalin 2-dependent inhibition of mycobacterial growth in alveolar epithelium

Journal of Immunology

Volumn 181, Issue 12, 2008, Pages 8521-8527

  Saiga, Hiroyuki ^a,b   Nishimura, Junichi ^a   Kuwata, Hirotaka ^b   Okuyama, Megumi ^a   Matsumoto, Sohkichi ^e   Sato, Shintaro ^c   Matsumoto, Makoto ^b   Akira, Shizuo ^c,d   Yoshikai, Yasunobu ^b   Honda, Kenya ^a   Yamamoto, Masahiro ^a   Takeda, Kiyoshi ^a,b,d  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d OSAKA UNIVERSITY   (Japan)

^e OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IRON; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ACUTE PHASE PROTEIN; LCN2 PROTEIN, MOUSE; LIPOCALIN; ONCOPROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; GROWTH INHIBITION; INNATE IMMUNITY; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG TUBERCULOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; ANIMAL; C57BL MOUSE; CELL LINE; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; LUNG ALVEOLUS; METABOLISM; MICROBIOLOGY; MOUSE MUTANT; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; PATHOLOGY; PHYSIOLOGY; RESPIRATORY TRACT MUCOSA; TRANSGENIC MOUSE; TUBERCULOSIS;

ACUTE-PHASE PROTEINS; ANIMALS; CELL LINE; LIPOCALINS; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; ONCOGENE PROTEINS; PULMONARY ALVEOLI; RESPIRATORY MUCOSA; TUBERCULOSIS;

EID: 58849133385     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.12.8521     Document Type: Article

References (41)

1. North, R. J., and Y. J. Jung. 2004. Immunity to tuberculosis. Annu. Rev. Immunol. 22: 599-623.
2. Kaufmann, S. H. 2006. Tuberculosis: back on the immunologists' agenda. Immunity 24: 351-357.
3. Quesniaux, V., C. Fremond, M. Jacobs, S. Parida, D. Nicolle, V. Yeremeev, F. Bihl, F. Erard, T. Botha, M. Drennan, et al. 2004. Toll-like receptor pathways in the immune responses to mycobacteria. Microbes Infect. 6: 946-959.
4. Fremond, C. M., V. Yeremeev, D. M. Nicolle, M. Jacobs, V. F. Quesniaux, and B. Ryffel. 2004. Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. J. Clin. Invest. 114: 1790-1799.
5. Aoki, K., S. Matsumoto, Y. Hirayama, T. Wada, Y. Ozeki, M. Niki, P. Domenech, K. Umemori, S. Yamamoto, A. Mineda, et al. 2004. Extracellular mycobacterial DNA-binding protein 1 participates in mycobacterium-lung epithelial cell interaction through hyaluronic acid. J. Biol. Chem. 279: 39798-39806.
6. Teitelbaum, R., W. Schubert, L. Gunther, Y. Kress, F. Macaluso, J. W. Pollard, D. N. McMurray, and B. R. Bloom. 1999. The M cell as a portal of entry to the lung for the bacterial pathogen Mycobacterium tuberculosis. Immunity 10: 641-651.
7. Bermudez, L. E., and F. J. Sangari. 2001. Cellular and molecular mechanisms internalization of mycobacteria by host cells. Microbes Infect. 3: 37-42.
8. Bermudez, L. E., F. J. Sangari, P. Kolonoski, M. Petrofsky, and J. Goodman. 2002. The efficiency of the translocation of Mycobacterium tuberculosis across bilayer of epithelial and endothelial cells as a model of the alveolar wall is consequence of transport within mononuclear phagocytes and invasion of alveolar epithelial cells. Infect. Immun. 70: 140-146.
9. Hernandez-Pando, R., M. Jeyanathan, G. Mengistu, D. Aguilar, H. Orozco, M. Harboe, G. A. Rook, and G. Bjune. 2000. Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection. Lancet 356: 2133-2138. (Pubitemid 32047949)
10. Ferguson, J. S., and L. S. Schlesinger. 2000. Pulmonary surfactant in innate immunity and the pathogenesis of tuberculosis. Tuber. Lung Dis. 80: 173-184. (Pubitemid 30842217)
11. Kjeldsen, L., J. B. Cowland, and N. Borregaard. 2000. Human neutrophil gelatinase- associated lipocalin and homologous proteins in rat and mouse. Biochim. Biophys. Acta 1482: 272-283. (Pubitemid 30780047)
12. Devireddy, L. R., J. G. Teodoro, F. A. Richard, and M. R. Green. 2001. Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science 293: 829-834.
13. Kjeldsen, L., A. H. Johnsen, H. Sengelov, and N. Borregaard. 1993. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J. Biol. Chem. 268: 10425-10432. (Pubitemid 23150227)
14. Flower, D. R., A. C. North, and T. K. Attwood. 1991. Mouse oncogene protein 24p3 is a member of the lipocalin protein family. Biochem. Biophys. Res. Commun. 180: 69-74.
15. Liu, Q., J. Ryon, and M. Nilsen-Hamilton. 1997. Uterocalin: a mouse acute phase protein expressed in the uterus around birth. Mol. Reprod. Dev. 46: 507-514. (Pubitemid 27149086)
16. Goetz, D. H., M. A. Holmes, N. Borregaard, M. E. Bluhm, K. N. Raymond, and R. K. Strong. 2002. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol. Cell 10: 1033-1043.
17. Nilsen-Hamilton, M., Q. Liu, J. Ryon, L. Bendickson, P. Lepont, and Q. Chang. 2003. Tissue involution and the acute phase response. Ann. NY Acad. Sci. 995: 94-108. (Pubitemid 36706617)
18. Devireddy, L. R., C. Gazin, X. Zhu, and M. R. Green. 2005. A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell 123: 1293-1305.
19. Yang, J., D. Goetz, J. Y. Li, W. Wang, K. Mori, D. Setlik, T. Du, H. Erdjument-Bromage, P. Tempst, R. Strong, and J. Barasch. 2002. An iron delivery pathway mediated by a lipocalin. Mol. Cell 10: 1045-1056.
20. Abergel, R. J., M. K. Wilson, J. E. Arceneaux, T. M. Hoette, R. K. Strong, B. R. Byers, and K. N. Raymond. 2006. Anthrax pathogen evades the mammalian immune system through stealth siderophore production. Proc. Natl. Acad. Sci. USA 103: 18499-18503.
21. Holmes, M. A., W. Paulsene, X. Jide, C. Ratledge, and R. K. Strong. 2005. Siderocalin (Lcn 2) also binds carboxymycobactins, potentially defending against mycobacterial infections through iron sequestration. Structure 13: 29-41.
22. Flo, T. H., K. D. Smith, S. Sato, D. J. Rodriguez, M. A. Holmes, R. K. Strong, S. Akira, and A. Aderem. 2004. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432: 917-921.
23. Berger, T., A. Togawa, G. S. Duncan, A. J. Elia, A. You-Ten, A. Wakeham, H. E. Fong, C. C. Cheung, and T. W. Mak. 2006. Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc. Natl. Acad. Sci. USA 103: 1834-1839.
24. Smith, K. D. 2007. Iron metabolism at the host pathogen interface: lipocalin 2 and the pathogen-associated iroA gene cluster. Int. J. Biochem. Cell Biol. 39: 1776-1780.
25. Houben, E. N., L. Nguyen, and J. Pieters. 2006. Interaction of pathogenic mycobacteria with the host immune system. Curr. Opin. Microbiol. 9: 76-85. (Pubitemid 43184340)
26. De Voss, J. J., K. Rutter, B. G. Schroeder, and C. E. Barry, 3rd. 1999. Iron acquisition and metabolism by mycobacteria. J. Bacteriol. 181: 4443-4451.
27. De Voss, J. J., K. Rutter, B. G. Schroeder, H. Su, Y. Zhu, and C. E. Barry, 3rd. 2000. The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages. Proc. Natl. Acad. Sci. USA 97: 1252-1257.
28. Gobin, J., and M. A. Horwitz. 1996. Exochelins of Mycobacterium tuberculosis remove iron from human iron-binding proteins and donate iron to mycobactins in the M. tuberculosis cell wall. J. Exp. Med. 183: 1527-1532.
29. Luo, M., E. A. Fadeev, and J. T. Groves. 2005. Mycobactin-mediated iron acquisition within macrophages. Nat. Chem. Biol. 1: 149-153.
30. Jat, P. S., M. D. Noble, P. Ataliotis, Y. Tanaka, N. Yannoutsos, L. Larsen, and D. Kioussis. 1991. Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse. Proc. Natl. Acad. Sci. USA 88: 5096-5100.
31. Whitehead, R. H., P. E. VanEeden, M. D. Noble, P. Ataliotis, and P. S. Jat. 1993. Establishment of conditionally immortalized epithelial cell lines from both colon and small intestine of adult H-2Kb-tsA58 transgenic mice. Proc. Natl. Acad. Sci. USA 90: 587-591. (Pubitemid 23028908)
32. deMello, D. E., S. Mahmoud, P. J. Padfield, and J. W. Hoffmann. 2000. Generation of an immortal differentiated lung type-II epithelial cell line from the adult H-2K(b)tsA58 transgenic mouse. In Vitro Cell. Dev. Biol. Anim. 36: 374-382.
33. Rook, G. A., B. R. Champion, J. Steele, A. M. Varey, and J. L. Stanford. 1985. I-A restricted activation by T cell lines of anti-tuberculosis activity in murine macrophages. Clin. Exp. Immunol. 59: 414-420.
34. Mori, K., H. T. Lee, D. Rapoport, I. R. Drexler, K. Foster, J. Yang, K. M. Schmidt-Ott, X. Chen, J. Y. Li, S. Weiss, et al. 2005. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J. Clin. Invest. 115: 610-621.
35. Martineau, A. R., S. M. Newton, K. A. Wilkinson, B. Kampmann, B. M. Hall, N. Nawroly, G. E. Packe, R. N. Davidson, C. J. Griffiths, and R. J. Wilkinson. 2007. Neutrophil-mediated innate immune resistance to mycobacteria. J. Clin. Invest. 117: 1988-1994.
36. Sato, K., H. Tomioka, T. Shimizu, T. Gonda, F. Ota, and C. Sano. 2002. Type II alveolar cells play roles in macrophage-mediated host innate resistance to pulmonary mycobacterial infections by producing proinflammatory cytokines. J. Infect. Dis. 185: 1139-1147.
37. Bermudez, L. E., and J. Goodman. 1996. Mycobacterium tuberculosis invades and replicates within type II alveolar cells. Infect. Immun. 64: 1400-1406.
38. Garcia-Perez, B. E., R. Mondragon-Flores, and J. Luna-Herrera. 2003. Internalization of Mycobacterium tuberculosis by macropinocytosis in non-phagocytic cells. Microb. Pathog. 35: 49-55. (Pubitemid 36952282)
39. Adams, D. O., and T. A. Hamilton. 1984. The cell biology of macrophage activation. Annu. Rev. Immunol. 2: 283-318.
40. MacMicking, J., Q. W. Xie, and C. Nathan. 1997. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15: 323-350.
41. Govoni, G., and P. Gros. 1998. Macrophage NRAMP1 and its role in resistance to microbial infections. Inflamm. Res. 47: 277-284.